N-acetyl-cysteine in the therapy of HIV-positive patients
Randomly selected asymptomatic HIV-positive persons reveal, on average, a massive daily loss of sulphur, which appears to represent in first approximation the mean loss throughout the asymptomatic stage, and may explain the widely observed decrease in cyst(e)ine and glutathione levels. This sulphur...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1999
|
| In: |
Current opinion in clinical nutrition & metabolic care
Year: 1999, Jahrgang: 2, Heft: 6, Pages: 493-498 |
| ISSN: | 1473-6519 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/co-clinicalnutrition/Fulltext/1999/11000/N_acetyl_cysteine_in_the_therapy_of_HIV_positive.11.aspx
|
| Verfasserangaben: | Wulf Dröge, Raoul Breitkreutz |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1747860018 | ||
| 003 | DE-627 | ||
| 005 | 20230426111242.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210209s1999 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1747860018 | ||
| 035 | |a (DE-599)KXP1747860018 | ||
| 035 | |a (OCoLC)1341392076 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Dröge, Wulf |d -2011 |e VerfasserIn |0 (DE-588)1178587789 |0 (DE-627)1049465539 |0 (DE-576)517837528 |4 aut | |
| 245 | 1 | 0 | |a N-acetyl-cysteine in the therapy of HIV-positive patients |c Wulf Dröge, Raoul Breitkreutz |
| 264 | 1 | |c 1999 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.02.2021 | ||
| 520 | |a Randomly selected asymptomatic HIV-positive persons reveal, on average, a massive daily loss of sulphur, which appears to represent in first approximation the mean loss throughout the asymptomatic stage, and may explain the widely observed decrease in cyst(e)ine and glutathione levels. This sulphur loss is reasonably expected to lead, within a few years, to a life-threatening condition and may, therefore, contribute decisively to disease progression. Importantly, the rate of sulphur loss is not ameliorated by highly active antiretroviral therapy and may contribute to antiretroviral treatment failure. Several clinical trials on N-acetyl-cysteine treatment of HIV-positive patients have revealed various therapeutic effects, but did not meet the rigorous standards for approval by the health authorities. | ||
| 700 | 1 | |a Breitkreutz, Raoul |e VerfasserIn |0 (DE-588)114206198 |0 (DE-627)620873620 |0 (DE-576)32047450X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current opinion in clinical nutrition & metabolic care |d London : Lippincott Williams & Wilkins, 1998 |g 2(1999), 6, Seite 493-498 |h Online-Ressource |w (DE-627)324455143 |w (DE-600)2026896-8 |w (DE-576)103189475 |x 1473-6519 |7 nnas |a N-acetyl-cysteine in the therapy of HIV-positive patients |
| 773 | 1 | 8 | |g volume:2 |g year:1999 |g number:6 |g pages:493-498 |g extent:6 |a N-acetyl-cysteine in the therapy of HIV-positive patients |
| 856 | 4 | 0 | |u https://journals.lww.com/co-clinicalnutrition/Fulltext/1999/11000/N_acetyl_cysteine_in_the_therapy_of_HIV_positive.11.aspx |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210209 | ||
| 993 | |a Article | ||
| 994 | |a 1999 | ||
| 998 | |g 1178587789 |a Dröge, Wulf |m 1178587789:Dröge, Wulf |d 50000 |e 50000PD1178587789 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1747860018 |e 3850187543 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Wulf Dröge, Raoul Breitkreutz"]},"origin":[{"dateIssuedDisp":"1999","dateIssuedKey":"1999"}],"id":{"eki":["1747860018"]},"physDesc":[{"extent":"6 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"London ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1998-","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedKey":"1998"}],"id":{"issn":["1473-6519"],"zdb":["2026896-8"],"eki":["324455143"]},"pubHistory":["1.1998 -"],"part":{"year":"1999","pages":"493-498","issue":"6","text":"2(1999), 6, Seite 493-498","volume":"2","extent":"6"},"note":["Gesehen am 17.10.05"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"N-acetyl-cysteine in the therapy of HIV-positive patientsCurrent opinion in clinical nutrition & metabolic care","recId":"324455143","language":["eng"],"title":[{"title_sort":"Current opinion in clinical nutrition & metabolic care","title":"Current opinion in clinical nutrition & metabolic care"}]}],"person":[{"given":"Wulf","family":"Dröge","role":"aut","roleDisplay":"VerfasserIn","display":"Dröge, Wulf"},{"roleDisplay":"VerfasserIn","display":"Breitkreutz, Raoul","role":"aut","family":"Breitkreutz","given":"Raoul"}],"title":[{"title":"N-acetyl-cysteine in the therapy of HIV-positive patients","title_sort":"N-acetyl-cysteine in the therapy of HIV-positive patients"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 09.02.2021"],"language":["eng"],"recId":"1747860018"} | ||
| SRT | |a DROEGEWULFNACETYLCYS1999 | ||